| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vaccinex, Inc. (VCNX) has 0 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. VCNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 27, 2018 | Royer Scott E. | Chief Financial Officer | Buy | 311 | $4.15 | $1,290.65 | New | |
| Aug 13, 2018 | Friedberg Albert | Director, 10% Owner | Buy | 2,458,333 | $12.00 | $29,499,996.00 | +84.4% |